Completed PHASE3 INTERVENTIONAL 2-arm NCT00598832

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris

Sponsor: Galderma R&D

Conditions Acne Vulgaris

Interventions Adapalene Lotion Vehicle Adapalene lotion 0.1%

Updated 8 times since 2017 Last updated: Feb 16, 2021 Started: Nov 30, 2007 Primary completion: Oct 31, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00598832, this PHASE3 trial focuses on Acne Vulgaris and remains completed. Sponsored by Galderma R&D, it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Mar 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Galderma R&D

Data source: Galderma R&D

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Augusta, United States , Austin, United States , Buffalo Grove, United States , Calgary, Canada , Clermont, United States , Denver, United States , Edmonton, Canada , Goodlettsville, United States , Hickory, United States and 24 more locations